Wednesday’s neck and neck research study revealed a weight reduction of 20.2% for Eli Lilly’s Zepbound and 13.7% for Novo Nordisk’s Wegovy.
发布者:BY MARKETWIRE,转转请注明出处:https://robotalks.cn/analysts-on-new-eli-lilly-obesity-data-confirms-consensus-on-zepbound-and-wegovy/